Interferon-  and tumor necrosis factor-  induce an immunoinhibitory molecule, B7-H1, via nuclear factor- B activation in blasts in myelodysplastic syndromes

Immune function parameters at diagnosis in patients with myelodysplastic syndromes: Correlation with the FAB classification and prognosis

(2010) Argiris Symeonidis et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

B7-H1 expression is regulated by MEK/ERK signaling pathway in anaplastic large cell lymphoma and Hodgkin lymphoma

(2009) Ryo Yamamoto et al.   CANCER SCIENCE

Functional B7.2 and B7-H2 Molecules on Myeloma Cells Are Associated with a Growth Advantage

(2009) T. Yamashita et al.   CLINICAL CANCER RESEARCH

Many are called MDS cell lines: One is chosen

(2009) Hans G. Drexler et al.   LEUKEMIA RESEARCH

B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells

(2008) T. Azuma et al.   BLOOD

Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways

(2008) Brian T. Fife et al.   IMMUNOLOGICAL REVIEWS

Aggressive characteristics of myeloblasts expressing CD7 in myelodysplastic syndromes

(2008) Chikako Satoh et al.   LEUKEMIA RESEARCH

Induced B7-H1 expression on human renal tubular epithelial cells by the sublytic terminal complement complex C5b-9

(2008) Yongwen Chen et al.   MOLECULAR IMMUNOLOGY